Nordic Nanovector Provides update on PARADIGME, its Phase 2b Pivotal Trial with Betalutin® in R/R Follicular Lymphoma

/PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) provides an update on the timeline for PARADIGME, its ongoing pivotal Phase 2b trial of Betalutin® (177Lu...

Related Keywords

Norway ,Erik Skullerud ,Malene Brondberg ,Frazer Hall Medi , ,Nordic Nanovector ,Chief Executive Officer ,Frazer Hall ,